Actively Recruiting
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
Led by University of Massachusetts, Worcester · Updated on 2025-06-15
144
Participants Needed
1
Research Sites
205 weeks
Total Duration
On this page
Sponsors
U
University of Massachusetts, Worcester
Lead Sponsor
N
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The U.S. Deaf community - a group of more than one million Americans who communicate using American Sign Language (ASL) - experiences nearly triple the rate of lifetime problem drinking and twice the rate of trauma exposure compared to the general population. Although there are several treatments for alcohol use disorder (AUD) and posttraumatic stress disorder (PTSD) in hearing populations, none have been developed for or tested with Deaf clients. To address these barriers, the study team developed Signs of Safety, a Deaf-accessible therapy toolkit for treating AUD and PTSD. Their aims are to conduct a nationwide, virtual clinical trial to compare (1) Signs of Safety with (2) treatment as usual and (3) a no treatment control, to collect data on clinical outcomes, and to explore potential mediators and moderators of outcome.
CONDITIONS
Official Title
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Self-identify as Deaf or hard-of-hearing
- Proficient in American Sign Language (ASL)
- Age 18 years or older
- Have access to videoconferencing technology for informed consent and therapy sessions
- Have access to online survey technology for study assessments
- Have problematic alcohol consumption indicated by AUDIT score 8 for men or 6 for women in the past month
- Have subthreshold or full PTSD symptoms on the PTSD Checklist for DSM-5 (PCL-5) in the past month
You will not qualify if you...
- Currently participating in formal psychotherapy (will be removed from study if psychotherapy begins during study)
- Unable to provide informed consent
- Under 18 years of age
- Prisoners
- Pregnant women (pregnancy status not assessed but pregnant women will not knowingly be included)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Massachusetts Medical School
Worcester, Massachusetts, United States, 01655
Actively Recruiting
Research Team
M
Melissa L Anderson
CONTACT
K
Kayla Meza
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here